Published in J Neurosci on October 22, 2014
Mitochondrial division and fusion in metabolism. Curr Opin Cell Biol (2015) 1.03
The role of mitochondrially derived ATP in synaptic vesicle recycling. J Biol Chem (2015) 0.98
DNM1L-related mitochondrial fission defect presenting as refractory epilepsy. Eur J Hum Genet (2015) 0.94
Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β. J Cell Biol (2015) 0.93
Dynamin-related protein 1 is required for normal mitochondrial bioenergetic and synaptic function in CA1 hippocampal neurons. Cell Death Dis (2015) 0.91
Mitochondria: A Therapeutic Target for Parkinson's Disease? Int J Mol Sci (2015) 0.85
Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat Rev Neurosci (2017) 0.84
Synaptic dysfunction, memory deficits and hippocampal atrophy due to ablation of mitochondrial fission in adult forebrain neurons. Cell Death Differ (2015) 0.84
Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP. Sci Rep (2016) 0.81
Role of protein kinase A in regulating mitochondrial function and neuronal development: implications to neurodegenerative diseases. Rev Neurosci (2015) 0.79
HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders. Neurobiol Dis (2015) 0.78
Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease. FEBS Lett (2015) 0.78
The Putative Drp1 Inhibitor mdivi-1 Is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species. Dev Cell (2017) 0.78
The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons. Neurotox Res (2016) 0.77
Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity. J Neuroinflammation (2016) 0.77
Dynamin-Related Protein 1 Deficiency Leads to Receptor-Interacting Protein Kinase 3-Mediated Necroptotic Neurodegeneration. Am J Pathol (2016) 0.76
Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons. eNeuro (2017) 0.75
Mitochondrial fission is an acute and adaptive response in injured motor neurons. Sci Rep (2016) 0.75
Alterations of mitochondrial dynamics allow retrograde propagation of locally initiated axonal insults. Sci Rep (2016) 0.75
Drosophila clueless is involved in Parkin-dependent mitophagy by promoting VCP-mediated Marf degradation. Hum Mol Genet (2016) 0.75
Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress. Sci Rep (2017) 0.75
Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition. Mol Neurobiol (2015) 0.75
Mitochondrial homeostasis in Parkinson's disease - a triumvirate rule? Neural Regen Res (2017) 0.75
Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson's disease. Sci Rep (2017) 0.75
Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease. Neurochem Int (2017) 0.75
An emerging role for mitochondrial dynamics in schizophrenia. Schizophr Res (2017) 0.75
The Leukocentric Theory of Neurological Disorder: A Manifesto. Neurochem Res (2017) 0.75
Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein? Dis Model Mech (2017) 0.75
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci (2009) 21.94
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J (2008) 12.89
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature (2009) 10.79
Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci (2000) 10.62
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A (1998) 8.41
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet (2004) 7.45
The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci U S A (2008) 7.41
OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet (2000) 7.20
Mitochondria: in sickness and in health. Cell (2012) 6.05
Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol (2010) 5.94
Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron (2008) 5.65
'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature (2007) 5.03
Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci U S A (2008) 4.97
Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron (2005) 4.87
Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol (2009) 4.78
PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease. Cell (2011) 4.00
Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron (2011) 3.89
Intracellular transport in neurons. Physiol Rev (1980) 3.83
The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice. J Cell Biol (2009) 3.49
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology (2007) 3.26
PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell (2009) 3.17
Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell (1995) 2.89
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol (2003) 2.85
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci U S A (2007) 2.77
Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron (2010) 2.75
Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A (2002) 2.64
Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci (2010) 2.55
An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J Neurosci (2002) 2.54
Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci (2009) 2.44
I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J Neurosci (2002) 2.43
Conversion of red fluorescent protein into a bright blue probe. Chem Biol (2008) 2.39
Vesicular glycolysis provides on-board energy for fast axonal transport. Cell (2013) 2.33
Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol (2005) 2.32
Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice. J Neurosci (2001) 2.29
Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A (2006) 2.29
The scaffold protein Atg11 recruits fission machinery to drive selective mitochondria degradation by autophagy. Dev Cell (2013) 2.24
Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J (2010) 2.12
Characterization of a mouse strain expressing Cre recombinase from the 3' untranslated region of the dopamine transporter locus. Genesis (2006) 2.08
Mitochondrial dynamics in neurodegeneration. Trends Cell Biol (2012) 1.99
The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem (2001) 1.99
Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem (2011) 1.96
Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol (2010) 1.88
Bax/Bak-dependent release of DDP/TIMM8a promotes Drp1-mediated mitochondrial fission and mitoptosis during programmed cell death. Curr Biol (2005) 1.87
Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. J Biol Chem (2001) 1.85
Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia. Proc Natl Acad Sci U S A (2006) 1.85
Ca(2+) homeostasis during mitochondrial fragmentation and perinuclear clustering induced by hFis1. J Biol Chem (2004) 1.84
Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet (2010) 1.83
Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science (1984) 1.72
Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances. J Neurosci (2010) 1.66
LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet (2012) 1.56
v-SNARE composition distinguishes synaptic vesicle pools. Neuron (2011) 1.54
Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem (2000) 1.49
Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J Neurosci (2000) 1.48
Dopamine-deficient mice are hypersensitive to dopamine receptor agonists. J Neurosci (2000) 1.45
Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage. J Cell Biol (2012) 1.44
In vitro identification and electrophysiological characterization of dopamine neurons in the ventral tegmental area. Neuropharmacology (2010) 1.42
Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons. Hum Mol Genet (2012) 1.42
Essential function of HIPK2 in TGFbeta-dependent survival of midbrain dopamine neurons. Nat Neurosci (2006) 1.36
Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurol (1997) 1.27
Selective actions of mitochondrial fission/fusion genes on metabolism-secretion coupling in insulin-releasing cells. J Biol Chem (2008) 1.25
Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists. J Neurosci (1998) 1.21
Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease. FASEB J (2011) 1.19
Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction. J Neurochem (2012) 1.19
Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit. Hum Mol Genet (2012) 1.13
Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia. J Neurosci (2009) 1.09
Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging (2004) 1.04
Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J Neurosci (1997) 1.04
Energy failure: does it contribute to neurodegeneration? Ann Neurol (2013) 0.98
α-Synuclein and mitochondria: partners in crime? Neurotherapeutics (2013) 0.95
Monoamine innervation of the forebrain: collateralization. Brain Res Bull (1983) 0.95
Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin. Neuroscience (1996) 0.95
Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in substantia nigra but not ventral tegmental area in the rat. Neuroscience (1998) 0.83
Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine. Brain Res Dev Brain Res (1992) 0.81